- Forums
- ASX - By Stock
- NTI
- Ann: Phase II/III autism trial shows further benefits
Ann: Phase II/III autism trial shows further benefits, page-6
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $54.83M |
Open | High | Low | Value | Volume |
5.4¢ | 5.4¢ | 5.3¢ | $11.05K | 208.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 124570 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 19196 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 124570 | 0.053 |
2 | 304480 | 0.052 |
1 | 5000 | 0.051 |
4 | 1520000 | 0.050 |
4 | 340863 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 19196 | 2 |
0.055 | 71548 | 2 |
0.056 | 63420 | 1 |
0.058 | 177059 | 2 |
0.059 | 128477 | 2 |
Last trade - 10.53am 21/10/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online